OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor
Joanna M. Lubieniecka, Jinko Graham, Daniel J. Heffner, et al.
Frontiers in Genetics (2013) Vol. 4
Open Access | Times Cited: 66
Joanna M. Lubieniecka, Jinko Graham, Daniel J. Heffner, et al.
Frontiers in Genetics (2013) Vol. 4
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng, Amit P. Bhavsar, Henk Visscher, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1079-1084
Open Access | Times Cited: 244
Folefac Aminkeng, Amit P. Bhavsar, Henk Visscher, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1079-1084
Open Access | Times Cited: 244
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
Folefac Aminkeng, Colin J.D. Ross, Shahrad R. Rassekh, et al.
British Journal of Clinical Pharmacology (2016) Vol. 82, Iss. 3, pp. 683-695
Open Access | Times Cited: 210
Folefac Aminkeng, Colin J.D. Ross, Shahrad R. Rassekh, et al.
British Journal of Clinical Pharmacology (2016) Vol. 82, Iss. 3, pp. 683-695
Open Access | Times Cited: 210
Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
Volker M. Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg
Pharmacology & Therapeutics (2019) Vol. 197, pp. 122-152
Open Access | Times Cited: 113
Volker M. Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg
Pharmacology & Therapeutics (2019) Vol. 197, pp. 122-152
Open Access | Times Cited: 113
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
Siew Lian Leong, Nathorn Chaiyakunapruk, Shaun Wen Huey Lee
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Siew Lian Leong, Nathorn Chaiyakunapruk, Shaun Wen Huey Lee
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P. Schneider, Fei Shen, Laura Gardner, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 43-51
Open Access | Times Cited: 88
Bryan P. Schneider, Fei Shen, Laura Gardner, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 43-51
Open Access | Times Cited: 88
Gold nanoparticle-based aptasensors: A promising perspective for early-stage detection of cancer biomarkers
Amir Atapour, Hossein Khajeh-Zadeh, Mostafa Shafie, et al.
Materials Today Communications (2022) Vol. 30, pp. 103181-103181
Closed Access | Times Cited: 54
Amir Atapour, Hossein Khajeh-Zadeh, Mostafa Shafie, et al.
Materials Today Communications (2022) Vol. 30, pp. 103181-103181
Closed Access | Times Cited: 54
Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics
Toufik Abdul‐Rahman, Alden Dunham, He Huang, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 4, pp. 101591-101591
Closed Access | Times Cited: 33
Toufik Abdul‐Rahman, Alden Dunham, He Huang, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 4, pp. 101591-101591
Closed Access | Times Cited: 33
Chemotherapy-Related Cardiac Dysfunction
Marijke Linschoten, Arco J. Teske, Maarten J. Cramer, et al.
Circulation Genomic and Precision Medicine (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Marijke Linschoten, Arco J. Teske, Maarten J. Cramer, et al.
Circulation Genomic and Precision Medicine (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
Sarju Ganatra, Anju Nohria, Sachin Shah, et al.
Cardio-Oncology (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 72
Sarju Ganatra, Anju Nohria, Sachin Shah, et al.
Cardio-Oncology (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 72
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
Christof Vulsteke, Alena M. Pfeil, Charlotte Maggen, et al.
Breast Cancer Research and Treatment (2015) Vol. 152, Iss. 1, pp. 67-76
Closed Access | Times Cited: 70
Christof Vulsteke, Alena M. Pfeil, Charlotte Maggen, et al.
Breast Cancer Research and Treatment (2015) Vol. 152, Iss. 1, pp. 67-76
Closed Access | Times Cited: 70
Real-time monitoring of daunorubicin pharmacokinetics with nanoporous electrochemical aptamer-based sensors in vivo
Sai-Nan Qin, Zhi-Qiang Jie, Liyang Chen, et al.
Sensors and Actuators B Chemical (2024) Vol. 411, pp. 135710-135710
Closed Access | Times Cited: 7
Sai-Nan Qin, Zhi-Qiang Jie, Liyang Chen, et al.
Sensors and Actuators B Chemical (2024) Vol. 411, pp. 135710-135710
Closed Access | Times Cited: 7
Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults
Quinn S. Wells, Olivia J. Veatch, Joshua P. Fessel, et al.
Pharmacogenetics and Genomics (2017) Vol. 27, Iss. 7, pp. 247-254
Open Access | Times Cited: 57
Quinn S. Wells, Olivia J. Veatch, Joshua P. Fessel, et al.
Pharmacogenetics and Genomics (2017) Vol. 27, Iss. 7, pp. 247-254
Open Access | Times Cited: 57
Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, et al.
Blood Advances (2020) Vol. 4, Iss. 4, pp. 762-775
Open Access | Times Cited: 37
Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, et al.
Blood Advances (2020) Vol. 4, Iss. 4, pp. 762-775
Open Access | Times Cited: 37
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Ching Ying Huang, Martin W. Nicholson, Jyun Yuan Wang, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110643-110643
Open Access | Times Cited: 21
Ching Ying Huang, Martin W. Nicholson, Jyun Yuan Wang, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110643-110643
Open Access | Times Cited: 21
Association of GSTM1 null variant with anthracycline‐related cardiomyopathy after childhood cancer—A Children's Oncology Group ALTE03N1 report
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Cancer (2020) Vol. 126, Iss. 17, pp. 4051-4058
Open Access | Times Cited: 31
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Cancer (2020) Vol. 126, Iss. 17, pp. 4051-4058
Open Access | Times Cited: 31
Pharmacogenomics and the Treatment of Acute Myeloid Leukemia
Juan Eduardo Megías‐Vericat, Pau Montesinos, María José Herrero, et al.
Pharmacogenomics (2016) Vol. 17, Iss. 11, pp. 1245-1272
Closed Access | Times Cited: 31
Juan Eduardo Megías‐Vericat, Pau Montesinos, María José Herrero, et al.
Pharmacogenomics (2016) Vol. 17, Iss. 11, pp. 1245-1272
Closed Access | Times Cited: 31
Cardioprotection in cancer therapy: novel insights with anthracyclines
Inbar Raber, Aarti Asnani
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 915-921
Closed Access | Times Cited: 27
Inbar Raber, Aarti Asnani
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 915-921
Closed Access | Times Cited: 27
Common genetic predisposition for heart failure and cancer
Tobias J. Pfeffer, Stefan Pietzsch, Denise Hilfiker‐Kleiner
Herz (2020) Vol. 45, Iss. 7, pp. 632-636
Open Access | Times Cited: 26
Tobias J. Pfeffer, Stefan Pietzsch, Denise Hilfiker‐Kleiner
Herz (2020) Vol. 45, Iss. 7, pp. 632-636
Open Access | Times Cited: 26
NOXA‐mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin‐treated human acute myeloid leukemia cells
Jing‐Ting Chiou, Nan‐Chieh Huang, Chia‐Hui Huang, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 11, pp. 7356-7375
Closed Access | Times Cited: 21
Jing‐Ting Chiou, Nan‐Chieh Huang, Chia‐Hui Huang, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 11, pp. 7356-7375
Closed Access | Times Cited: 21
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection
Martino Deidda, Rosalinda Madonna, Ruggiero Mango, et al.
Journal of Cardiovascular Medicine (2016) Vol. 17, pp. e76-e83
Closed Access | Times Cited: 26
Martino Deidda, Rosalinda Madonna, Ruggiero Mango, et al.
Journal of Cardiovascular Medicine (2016) Vol. 17, pp. e76-e83
Closed Access | Times Cited: 26
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients
Sara Ruiz‐Pinto, Guillermo Pita, Miguel Martín, et al.
Breast Cancer Research and Treatment (2017) Vol. 167, Iss. 1, pp. 249-256
Open Access | Times Cited: 26
Sara Ruiz‐Pinto, Guillermo Pita, Miguel Martín, et al.
Breast Cancer Research and Treatment (2017) Vol. 167, Iss. 1, pp. 249-256
Open Access | Times Cited: 26
hiPSCs in cardio-oncology: deciphering the genomics
Emily Pinheiro, K. Ashley Fetterman, Paul W. Burridge
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 935-948
Open Access | Times Cited: 24
Emily Pinheiro, K. Ashley Fetterman, Paul W. Burridge
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 935-948
Open Access | Times Cited: 24
Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
Xinyu Yang, Guoping Li, Tao Yang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 22
Xinyu Yang, Guoping Li, Tao Yang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 22
Doxorubicin Cardiotoxicity: Pathophysiology Updates
Christopher W. Hoeger, Cole Turissini, Aarti Asnani
Current Treatment Options in Cardiovascular Medicine (2020) Vol. 22, Iss. 11
Closed Access | Times Cited: 21
Christopher W. Hoeger, Cole Turissini, Aarti Asnani
Current Treatment Options in Cardiovascular Medicine (2020) Vol. 22, Iss. 11
Closed Access | Times Cited: 21
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 559-559
Open Access | Times Cited: 13
Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 559-559
Open Access | Times Cited: 13
